Skip to Content


Friday, May 8, 2015


8:00 Registration & Continental Breakfast

9:00 Welcome & Introduction – Lee Wilke, MD, FACS

I. Neoadjuvant Therapy and Breast Cancer Subtypes
Moderator: Lee Wilke, MD, FACS
9:15 Why Neoadjuvant Therapy – Mark Burkard, MD, PhD
9:45 Triple Negative Breast Cancer – Kari Wisinski, MD
10:15 Neoadjuvant Endocrine Therapy for Breast Cancer – Ruth O’Regan, MD
10:45 Neoadjuvant Therapy for HER2 Positive Breast Cancer – Amye Tevaarwerk, MD

11:15 Panel Discussion

II. The Patient’s Perspective for Neoadjuvant Therapy
Moderators: Lee Wilke, MD, FACS and Ruth O’Regan, MD
11:30 Patient and Provider Panel Discussion


12:30 LUNCH

III. Issues Specific to Neoadjuvant Breast Cancer Therapy
Moderator: Lee Wilke, MD, FACS
1:30 What Breast Imaging Do You Need Before and After Neoadjuvant Therapy? – Amy Fowler, MD, PhD
2:00 Lymph Node-Negative Breast Cancer – Lee Wilke, MD, FACS
2:30 Lymph Node-Positive Breast Cancer – Jennifer Steiman, MD
2:50 Pathologic Response to Neoadjuvant Therapy – Josephine Harter, MD

3:10 Refreshment Break

3:30 Influence of Radiotherapy Choices – Bethany Anderson, MD
3:50 Breast Reconstruction after Chemotherapy – Ahmed Afifi, MD

4:15 Multidisciplinary Case Panel Discussion – All Faculty

4:45 Adjourn

5:00 Light Reception and Dinner Copyright © 2017 The Board of Regents of the University of Wisconsin System